Neuland Laboratories has announced a capital expenditure of ₹189 crores for setting up a new Research & Development (R&D) Center at its leased premises in Genome Valley, Hyderabad. This investment will facilitate the relocation and expansion of the existing R&D capabilities, upgrading to a state-of-the-art facility spanning approximately 1.35 lakh sq. ft. The project is financed through borrowings and internal accruals.
R&D Center Expansion
Neuland Laboratories has approved a capital expenditure of ₹189 crores to establish a new Research and Development (R&D) Center. The announcement was made on November 28, 2025, following a board meeting. This strategic investment aims to enhance the company’s research capabilities and support future growth.
Project Details
The new R&D Center will be located at the company’s leased premises in Genome Valley, Plot No. 15B, Phase-I, MN Park, Shamirpet, Turkapally, Hyderabad, Telangana. The existing R&D center, which is approximately 0.45 lakh sq. ft., will be relocated to a new facility with a built-up area of about 1.35 lakh sq. ft.
Funding
The project will be financed through a combination of borrowings and internal accruals.
Rationale
The primary rationale behind this investment is to relocate and expand the existing R&D center to a larger, state-of-the-art facility, allowing for enhanced research and development activities.
Source: BSE